Whan In Pharm Co.,Ltd. (KRX:016580)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,570
-10 (-0.09%)
Last updated: Dec 5, 2025, 10:52 AM KST
-3.34%
Market Cap 177.25B
Revenue (ttm) 256.32B
Net Income (ttm) 15.17B
Shares Out 15.27M
EPS (ttm) 978.53
PE Ratio 11.86
Forward PE 12.58
Dividend 300.00 (2.59%)
Ex-Dividend Date Dec 29, 2025
Volume 4,415
Average Volume 23,171
Open 11,580
Previous Close 11,580
Day's Range 11,540 - 11,620
52-Week Range 10,050 - 13,210
Beta 0.22
RSI 55.76
Earnings Date Nov 13, 2025

About Whan In Pharm

Whan In Pharm Co.,Ltd. manufactures and sells various pharmaceutical products in South Korea. The company offers products such as gastrointestinal, respiratory, cardiovascular, antidiabetic, antibiotic, antifungal, antihistamine, antiviral, antirheumatic, muscle relaxant, nonsteroidal anti-inflammatory, smoking cessation, erectile dysfunction, prostate disease, urinary disorder, osteoporosis, antiseizure, antidepressant, antipsychotic, central nervous system stimulant, anti-dementia, nootropic, alcohol use disorder, anti-Parkinson, multivitamin... [Read more]

Sector Healthcare
Founded 1978
Employees 601
Stock Exchange Korea Stock Exchange
Ticker Symbol 016580
Full Company Profile

Financial Performance

In 2024, Whan In Pharm's revenue was 259.60 billion, an increase of 12.68% compared to the previous year's 230.39 billion. Earnings were 23.38 billion, a decrease of -21.47%.

Financial Statements

News

There is no news available yet.